Results 31 to 40 of about 26,268,552 (306)

Optimizing the first-line fertility treatment

Gynecological Endocrinology, 2018
The objective of this study was to identify sperm score thresholds to achieve satisfactory intrauterine insemination (IUI) success rates according to the response to stimulation with clomiphene citrate (CC). To minimize the confounding effect of female age, we included only CC/IUI cycles of women ≤35 years old.
Mohamad, Irani, Stephen, Chow, Derek, Keating, Simone, Elder, Zev, Rosenwaks, Gianpiero, Palermo   +5 more
openaire   +2 more sources

Promptness of oxytocin administration for first-line treatment of postpartum hemorrhage: a national vignette-based study among midwives

BMC Pregnancy and Childbirth, 2022
Background Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality worldwide. Midwives play a key role in the initial management of PPH.
S. Voillequin, P. Rozenberg, Ph. Ravaud, A. Rousseau   +3 more
doaj   +1 more source

Treatment-free interval in the total cohort following first-line and subsequent lines of therapy.

, 2020
Treatment-free interval in the total cohort following first-line and subsequent lines of therapy.
Toby A. Eyre (8479401), Grant Vallance (6078815), Susan McLain-Smith (8479398), Sally Moore (6078818), Faye A. Sharpley (8479395), Jaimal Kothari (6078821), Karthik Ramasamy (795392), Faouzi Djebbari (6004379)   +7 more
core   +1 more source

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

New England Journal of Medicine, 2017
Rituximab-based immunochemotherapy has improved outcomes in patients with follicular lymphoma. Obinutuzumab is a glycoengineered type II anti-CD20 monoclonal antibody. We compared rituximab-based chemotherapy with obinutuzumab-based chemotherapy in patients with previously untreated advanced-stage follicular lymphoma.We randomly assigned patients to ...
Marcus, Robert, Davies, Andrew, Ando, Kiyoshi, Klapper, Wolfram, Opat, Stephen, Owen, Carolyn, Phillips, Elizabeth, Sangha, Randeep, Schlag, Rudolf, Seymour, John F, Townsend, William, Trněný, Marek, Wenger, Michael, Fingerle-Rowson, Günter, Rufibach, Kaspar, Moore, Tom, Herold, Michael, Hiddemann, Wolfgang   +17 more
openaire   +3 more sources

First-line treatment choice by age at diagnosis.

, 2018
First-line treatment choice by age at diagnosis.
Kristiina Kananen (6054188), Kari Remes (6054176), Tiina M. Järvinen (256223), Marta Pisini (6054194), Mervi Putkonen (5774924), Frida Schain (291265), Tricia Dixon (6054200), Venla Terävä (6054185), Hanna Ollikainen (6054182), Päivi Castren-Kortegangas (6054191), Amy Leval (350406), Pekka Anttila (6054179), Felix Wahl (6054197), Raija Silvennoinen (3088212), Marjatta Sinisalo (210631)   +14 more
core   +1 more source

Treatment-free interval in months according to age, following first-line and subsequent lines of therapy.

, 2020
Treatment-free interval in months according to age, following first-line and subsequent lines of therapy.
Toby A. Eyre (8479401), Grant Vallance (6078815), Susan McLain-Smith (8479398), Sally Moore (6078818), Faye A. Sharpley (8479395), Jaimal Kothari (6078821), Karthik Ramasamy (795392), Faouzi Djebbari (6004379)   +7 more
core   +1 more source

Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials [PDF]

, 2012
Purpose: This study investigated the impact of specific mutations in codon 12 of the Kirsten-ras (KRAS) gene on treatment efficacy in patients with metastatic colorectal cancer (mCRC).
Zielinski, Christoph C., Neumann, Jens, Stintzing, Sebastian, Ocvirk, Janja, Heinemann, Volker, Kurteva, Galina, Jung, Andreas, Modest, Dominik P., Brodowicz, Thomas, Knittelfelder, Regina, Kirchner, Thomas, Papai, Zsuzsanna, Laubender, Ruediger P.   +12 more
core   +1 more source

Doxycycline: a first-line treatment for bullous pemphigoid? [PDF]

The Lancet, 2017
No description ...
Henry Grantham, Deborah D. Stocken, Nicholas Reynolds   +2 more
openaire   +5 more sources

Efficacy of Gemcitabine and Vinorelbine in First-line Treatment 
with Advanced Non-small Cell Lung Cancer: A Multicentre Retrospective Study

Chinese Journal of Lung Cancer, 2012
Background and objective Chemotherapy has become the mainstay of first-line therapy. Non-platinum containing drugs are characterized by favorable toxicity profiles and is better tolerated than platinum-based regimens.
Yongfeng YU, Li ZHANG, Zhisheng REN, Jiujun ZHAO, Zhongrui LI, Shun LU   +5 more
doaj   +1 more source

Re-think first-line tuberculosis treatment [PDF]

European Respiratory Journal, 2013
To the Editor: In the June issue of the European Respiratory Journal ( ERJ ), A. Skrahina and co-workers reported alarming rates of multidrug-resistant tuberculosis (MDR-TB) in Minsk, Belarus. In their survey, they diagnosed MDR-TB in 35.3% of new patients and 76.5% of previously treated patients [1].
Ingen, J. van, Anthony, R.M.
openaire   +3 more sources